Abstract
Endometriosis (EM) is a prevalent gynecological disorder linked to pelvic pain, menstrual disturbances, and infertility. Despite its clinical burden, the molecular mechanisms underlying EM remain elusive, necessitating the discovery of novel biomarkers and therapeutic targets. This study explored the role of colony-stimulating factor 1 receptor (CSF1R) in EM through an integrative approach combining bioinformatics and experimental validation. Differentially expressed genes (DEGs) were identified from the GSE11691 dataset using the limma package. Weighted Gene Co-expression Network Analysis (WGCNA) identified disease-associated gene modules. A Protein-Protein Interaction (PPI) network was constructed, and candidate genes were selected using Least Absolute Shrinkage and Selection Operator (LASSO) and Random Forest algorithms. Expression and function of CSF1R were validated in hEM15A cells via RT-qPCR, Western blotting, CCK-8, EdU, wound healing, and Transwell assays. WGCNA and PPI network analysis revealed a significant enrichment of genes within the PI3K/AKT/mTOR signaling pathway. Cross-validation using LASSO and Random Forest identified THBS2, CSF1R, IL-4R, and FLT1 as potential biomarkers. Among them, CSF1R was found to be significantly overexpressed in endometriotic stromal cells. Knockdown of CSF1R markedly suppressed cell proliferation, migration, and invasion, accompanied by decreased p-AKT expression. Rescue experiments using an AKT activator partially reversed these effects, supporting the functional role of CSF1R in modulating the AKT signaling pathway. CSF1R promotes the progression of endometriosis by modulating AKT signaling. It may serve as a valuable diagnostic biomarker and therapeutic target, providing new insights into endometriosis pathogenesis and treatment strategies.
Similar content being viewed by others
References
Hung SW, et al. Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review. Med Res Rev. 2021;41(4):2489–564.
Wang Z, et al. Integrated bioinformatics analysis uncovers characteristic genes and molecular subtyping system for endometriosis. Front Pharmacol. 2022;13:932526.
Parazzini F, et al. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017;209:3–7.
Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–56.
Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018;131(3):557–71.
Ianieri MM, Mautone D, Ceccaroni M. Recurrence in deep infiltrating endometriosis: A systematic review of the literature. J Minim Invasive Gynecol. 2018;25(5):786–93.
Kim HS, et al. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer. 2014;110(7):1878–90.
Ling F, Lu Q. 100 calcium-binding protein A10 contributes to malignant traits in osteosarcoma cells by regulating glycolytic metabolism via the AKT/mTOR pathway. Bioengineered. 2022;13(5):12298–308.
Yue Y et al. Impact of microparticle transarterial chemoembolization (mTACE) on myeloid-derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications. 2024;12(9):e70007.
Zhang Y et al. AFAP1-AS1 promotes the proliferation, migration and invasion of endometrial stromal cells from endometriosis through regulating the PI3K/AKT pathway. Minerva Med. 2023.
Zhu S, et al. The cGAS-STING pathway promotes endometriosis by up-regulating autophagy. Int Immunopharmacol. 2023;117:109644.
Zhao X, et al. BIBR1532 affects endometrial cell proliferation, migration, and invasion in endometriosis via telomerase inhibition and MAPK signaling. Gynecol Obstet Invest. 2023;88(4):226–39.
Bae S-J, et al. Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics. Front Endocrinol. 2022;13:942368.
Wu J, Fang X, Xia X. Identification of key genes and pathways associated with endometriosis by weighted gene co-expression network analysis. 2021;18(15):3425.
He Y et al. Identification and analysis of potential immune-related biomarkers in endometriosis. 2023;2023(1):2975581.
Hua F et al. Colony-stimulating factor 1 receptor inhibition blocks macrophage infiltration and endometrial cancer cell proliferation. 2019;19(4):3139–3147.
Yang C, et al. Machine learning approaches for predicting high cost high need patient expenditures in health care. Biomed Eng Online. 2018;17(Suppl 1):131.
Ellis K, et al. A random forest classifier for the prediction of energy expenditure and type of physical activity from wrist and hip accelerometers. Physiol Meas. 2014;35(11):2191–203.
Zhang M, et al. An immune-related signature predicts survival in patients with lung adenocarcinoma. Front Oncol. 2019;9:1314.
Alderden J, et al. Predicting pressure injury in critical care patients: A machine-learning model. Am J Crit Care. 2018;27(6):461–8.
Li S et al. GlycoSLASH: concurrent glycopeptide identification from multiple related LC-MS/MS data sets by using spectral clustering and library searching. 2023;22(5):1501–9.
Yu J et al. Metabolomic biomarkers and altered phenylalanine metabolic pathway in preschool children with atopic dermatitis–A pilot study. 2024;1–8.
Chen J et al. Hyper activation of beta-catenin signalling induced by IKKepsilon inhibition thwarts colorectal cancer cell proliferation. Cell Prolif, 2017. 50(4).
Lin K, et al. Autocrine production of interleukin-34 promotes the development of endometriosis through CSF1R/JAK3/STAT6 signaling. Sci Rep. 2019;9(1):16781.
Murga-Zamalloa C, et al. Colony-stimulating factor 1 receptor (CSF1R) activates AKT/mTOR signaling and promotes T-cell lymphoma viability. Clin Cancer Res. 2020;26(3):690–703.
Zhang L, et al. Estrogen stabilizes hypoxia-inducible factor 1alpha through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis. Fertil Steril. 2017;107(2):439–47.
Zhang X et al. Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway. Mol Med Rep, 2023;28(5).
Dunn TN et al. Inhibition of CSF1R and KIT with pexidartinib reduces inflammatory signaling and cell viability in endometriosis. Endocrinology. 2024.
Rattanaburee T, et al. Inhibition of CSF1R and AKT by (+/-)-kusunokinin hinders breast cancer cell proliferation. Biomed Pharmacother. 2020;129:110361.
Acknowledgements
We thank the participants and medical staffs involved in the sample collection and experimental procedures. Special thanks to the laboratory team for their contributions to the data analysis and interpretation.
Funding
This work was supported by the Science and Technology Innovation Project of Shanghai Putuo District Health System (No. ptkwws202405).
Author information
Authors and Affiliations
Contributions
LY, JS and LZ conceived and designed research. CL and CC conducted experiments. QC and HZ contributed analytical tools. PD, XW and YH analyzed data. LY and JS wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Ethical Approval
This study was approve by the ethics committee of the Shanghai Putuo Maternity & Infant Health Hospital (PFYLL-2024001).
Consent to Publish
Written informed consent was obtained from all participants prior to their enrollment and sample collection, including explicit consent for publication.
Conflict of Interest
The authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ye, L., Sun, J., Lu, C. et al. Novel Insights into the Pathogenic Role of CSF1R in Endometriosis. Reprod. Sci. (2026). https://doi.org/10.1007/s43032-026-02095-7
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1007/s43032-026-02095-7
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.